| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07158489 Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced… |
Recruitment opened |
| 2026-08-01 | NCT07574047 MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced… |
Phase changed: Phase 4 -> Phase 2 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT02051218 | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks… | Metastatic Breast Cancer | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07149649 | Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) | Metastatic NSCLC - Non-Small Cell Lung Cancer | Recruiting |
| Phase 2 | |||
| NCT06452394 | NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline | Breast Cancer | Recruiting |
| NCT06835049 | Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk… | Sarcoma,Soft Tissue | Recruiting |
| NCT06358573 | Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early… | Triple-negative Breast Cancer | Recruiting |
| NCT07020065 | Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in… | Metastatic NSCLC - Non-Small Cell Lung Cancer | Recruiting |
| NCT06401980 | Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT07365423 | Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) | Recurrent Prostate Cancer | Recruiting |
| NCT07158489 | Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced… | NSCLC | Recruiting |
| NCT03620669 | 1st Line Durvalumab in PS 2 NSCLC Patients | NSCLC Stage IV | Active, Not Recruiting |
| NCT04472949 | Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and… | Small Cell Lung Cancer | Active, Not Recruiting |
| NCT04604067 | Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter… | Diffuse Large B-cell Lymphoma | Active, Not Recruiting |
| NCT03937843 | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma | Seminoma | Active, Not Recruiting |
| NCT04630730 | Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients… | Bladder Cancer | Active, Not Recruiting |
| NCT04245514 | Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT07593482 | Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen… | B-cell Lymphoma | Not Yet Recruiting |
| NCT07574047 | MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced… | Melanoma | Not Yet Recruiting |
| Not specified | |||
| NCT06114108 | Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV… | Non-small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT07617610 | Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic… | Metastatic Colorectal Cancer | Recruiting |
| NCT04024475 | Prostate Cancer Biobank | Prostatic Neoplasms | Active, Not Recruiting |
| NCT06090162 | LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell… | Non-hodgkin Lymphoma, B Cell | Active, Not Recruiting |